Prices delayed by at least 15 minutes | Print


LeMaitre Vascular (LMAT)

Common Shares
Sell: $75.79|Buy: $75.93|Change: 0.90 (1.20%)

Open 

$75.32


Previous close 

$75


Trade high 

$76.19


Volume 

253,869


Year high 

$76.24


Year low 

$44.27


Dividend yield 

0.77%


Market capitalisation 

$1.70 bn


P/E ratio 

49.67


ISIN 

US5255582018


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Dividends

PreviousLatest
Record date14/03/202416/05/2024
Ex-dividend date13/03/202415/05/2024
Payment date28/03/202430/05/2024
Amount$0.16$0.16

Performance 07/05/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
LeMaitre Vascular+ 1.20
More...

Company profile

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.